Women win this one: Males do worse than females when sick with Zika

It’s a battle you didn’t see coming in the war between the sexes. 

In a research setting, males infected with Zika virus get significantly sicker than their female counterparts even when both are dosed with the same viral load.

In this case, the subjects were mice. However, the researchers behind the finding point out that such sex-based differences are consistent with epidemiological data on Zika and other infections in humans. 

The prior and present evidence suggests men infected with Zika are more susceptible to neurological complications like Guillain-Barré syndrome. 

As with the mice, this holds despite comparable or even higher infection rates in females. 

“In our study, using a model of virus-induced neuroinflammation during ZIKV infection, we found that male mice develop an exacerbated neuroinflammatory response and more severe neurological symptoms than female mice, suggesting a potential sex bias in susceptibility to virus-induced neuropathology,” write corresponding author Ali Ashkar, PhD, DVM, and colleagues at McMaster University in Ontario. 

“Our findings demonstrate that sexually dimorphic immune responses contribute to increased male susceptibility to virus-induced neuropathology.”

The study is current in the Journal of Infectious Diseases. 

Biological sex matters 

In their discussion section, Ashkar and co-researchers state they conducted the study because it has previously been shown that biological sex “fundamentally shapes” immune responses—but how these differences “translate into clinical outcomes during viral infection” is not well understood. 

“Although the mechanisms underlying these sex differences remain unclear, sex hormones may contribute to the distinct inflammatory responses observed between males and females,” the authors write. “The potential contribution of sex hormones to these differences warrants further investigation.

Inflammation-prone males 

In a news item posted by the university, PhD candidate Alexa Mansour, lead author of the present study, remarks that the team’s findings—when considered alongside a growing body of scientific literature arriving at similar conclusions—suggest “it’s really important to consider biological sex in the context of infectious disease going forward.” 

Ashkar adds that, from now on, for any acute viral infection, “it’s important for physicians to control inflammation early in male patients.”

More:

‘We already have a lot of approved and effective anti-inflammatory medications, so we don’t necessarily need new interventions to do this. We just need to acknowledge that male patients might be more susceptible to severe disease and tailor our treatment plans accordingly.’

Read the full study here and the university news item here.

 

Subscribe to Health Exec News

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Subscribe to Health Exec News

Subscribe to Health Exec News